Jun 21, 2023 8:15am EDT DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
May 30, 2023 8:29am EDT DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors
May 15, 2023 4:28pm EDT DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results
May 08, 2023 8:50am EDT DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023
Mar 28, 2023 4:30pm EDT DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results
Mar 20, 2023 4:17pm EDT DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023
Mar 13, 2023 8:00am EDT DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference
Mar 06, 2023 8:30am EST DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
